-
Drug efficacy at G protein-coupled receptors.
Annu Rev Pharmacol Toxicol. 2002;42:349-79
PMID: 11807176
-
A modification of receptor theory.
Br J Pharmacol Chemother. 1956 Dec;11(4):379-93
PMID: 13383117
-
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
Science. 2005 Mar 4;307(5714):1434-40
PMID: 15637236
-
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.
Trends Pharmacol Sci. 2007 Aug;28(8):407-15
PMID: 17629960
-
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands.
Virology. 2007 Aug 1;364(2):281-90
PMID: 17428518
-
Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Mol Pharmacol. 2006 Nov;70(5):1575-84
PMID: 16901982
-
Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.
Trends Pharmacol Sci. 1995 Jul;16(7):232-8
PMID: 7667897
-
Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies.
Mol Pharmacol. 2000 May;57(5):1000-10
PMID: 10779385
-
Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Eur J Pharmacol. 1996 Feb 22;297(3):283-91
PMID: 8666061
-
Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
J Med Chem. 1995 Sep 1;38(18):3469-81
PMID: 7658434
-
Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
Mol Pharmacol. 1994 May;45(5):997-1003
PMID: 8190115
-
Regulation of alpha2AR trafficking and signaling by interacting proteins.
Biochem Pharmacol. 2007 Apr 15;73(8):1135-45
PMID: 17229402
-
Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.
Nat Biotechnol. 2010 Sep;28(9):943-9
PMID: 20711173
-
Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.
Mol Pharmacol. 2009 Feb;75(2):381-96
PMID: 18996972
-
G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction.
Cell Signal. 2002 Apr;14(4):297-309
PMID: 11858937
-
Transduction of receptor signals by beta-arrestins.
Science. 2005 Apr 22;308(5721):512-7
PMID: 15845844
-
Beta-arrestin-biased ligands at seven-transmembrane receptors.
Trends Pharmacol Sci. 2007 Aug;28(8):416-22
PMID: 17644195
-
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
Br J Pharmacol. 1985 Feb;84(2):561-71
PMID: 3978322
-
Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.
J Pharmacol Exp Ther. 2009 Jan;328(1):331-42
PMID: 18824613
-
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
Neuropsychopharmacology. 1999 Jun;20(6):612-27
PMID: 10327430
-
Multiple signaling states of G-protein-coupled receptors.
Pharmacol Rev. 2005 Jun;57(2):147-61
PMID: 15914464
-
Implementation of BacMam virus gene delivery technology in a drug discovery setting.
Drug Discov Today. 2007 May;12(9-10):396-403
PMID: 17467576
-
Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias.
J Biol Chem. 2010 Mar 5;285(10):7459-74
PMID: 20051519
-
G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function.
Clin Exp Pharmacol Physiol. 2005 Nov;32(11):979-87
PMID: 16405456
-
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.
Pharmacol Rev. 2010 Jun;62(2):265-304
PMID: 20392808
-
Operational models of pharmacological agonism.
Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62
PMID: 6141562
-
Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
J Biol Chem. 2009 May 1;284(18):11953-62
PMID: 19254952
-
STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE.
Br J Pharmacol Chemother. 1964 Apr;22:356-65
PMID: 14190470
-
GPCR functional selectivity has therapeutic impact.
Trends Pharmacol Sci. 2007 Aug;28(8):390-6
PMID: 17629962
-
Composition and function of g protein-coupled receptor signalsomes controlling mitogen-activated protein kinase activity.
J Mol Neurosci. 2005;26(2-3):253-64
PMID: 16012199
-
Multiple mechanisms of serotonergic signal transduction.
Life Sci. 1987 Aug 31;41(9):1051-64
PMID: 2441225
-
Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
J Biomol Screen. 2009 Mar;14(3):246-55
PMID: 19211780
-
The ethyleneiminium ion as the active species in 2-haloalkylamine compounds.
Br J Pharmacol Chemother. 1957 Dec;12(4):489-97
PMID: 13489180
-
'7TM receptor allostery: putting numbers to shapeshifting proteins.
Trends Pharmacol Sci. 2009 Sep;30(9):460-9
PMID: 19729207
-
Analysis of allosterism in functional assays.
J Pharmacol Exp Ther. 2005 Nov;315(2):740-54
PMID: 16046613